Tvardi Therapeutics (TVRD) Current Assets: 2013-2017
Historic Current Assets for Tvardi Therapeutics (TVRD) over the last 4 years, with Sep 2017 value amounting to $106.0 million.
- Tvardi Therapeutics' Current Assets rose 37.60% to $106.0 million in Q3 2017 from the same period last year, while for Sep 2017 it was $106.0 million, marking a year-over-year increase of 37.60%. This contributed to the annual value of $61.4 million for FY2016, which is 43.59% down from last year.
- According to the latest figures from Q3 2017, Tvardi Therapeutics' Current Assets is $106.0 million, which was down 8.49% from $115.8 million recorded in Q2 2017.
- In the past 5 years, Tvardi Therapeutics' Current Assets registered a high of $115.8 million during Q2 2017, and its lowest value of $14.6 million during Q4 2013.
- In the last 3 years, Tvardi Therapeutics' Current Assets had a median value of $89.1 million in 2016 and averaged $82.5 million.
- Per our database at Business Quant, Tvardi Therapeutics' Current Assets soared by 265.09% in 2014 and then crashed by 58.75% in 2017.
- Tvardi Therapeutics' Current Assets (Quarterly) stood at $14.6 million in 2013, then surged by 265.09% to $53.1 million in 2014, then skyrocketed by 104.96% to $108.9 million in 2015, then tumbled by 43.59% to $61.4 million in 2016, then soared by 37.60% to $106.0 million in 2017.
- Its last three reported values are $106.0 million in Q3 2017, $115.8 million for Q2 2017, and $41.0 million during Q1 2017.